Reading Time: 2 minutesIntroduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a cornerstone in the management of type 2 diabetes and obesity. Its efficacy, however, varies among individuals, prompting a deeper exploration into the genetic factors that may influence its …


